Locations:
Search
Genetic variants exist irrespective of family history or other contributing factors
Study shows significantly reduced risk of mortality and disease complications in patients receiving GLP-1 agonists
Structured interventions enhance sleep, safety and caregiver resiliency in high-acuity units
Addressing rare disease and challenging treatment course in an active young patient
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Large retrospective study suggests DOACs are safe, effective alternative to low-molecular-weight heparin in complex patient population
Study shows high rate of hematologic responses, low rate of disease progression
Bispecific antibody bridging therapy deepens durability of BCMA CAR T-cell therapy without overlapping toxicities in patients with relapsed/refractory multiple myeloma
Phase 2 study brings pivotal advances in treatment efficacy and safety for the most challenging-to-treat population
Advances in genomics, spinal fluid analysis, wearable-based patient monitoring and more
Patient with quadruple refractory multiple myeloma achieves complete response with cell therapy
Advertisement
Advertisement